Surflex-Dock 2.1: Robust performance from ligand energetic modeling, ring flexibility, and knowledge-based search
- 945 Downloads
The Surflex flexible molecular docking method has been generalized and extended in two primary areas related to the search component of docking. First, incorporation of a small-molecule force-field extends the search into Cartesian coordinates constrained by internal ligand energetics. Whereas previous versions searched only the alignment and acyclic torsional space of the ligand, the new approach supports dynamic ring flexibility and all-atom optimization of docked ligand poses. Second, knowledge of well established molecular interactions between ligand fragments and a target protein can be directly exploited to guide the search process. This offers advantages in some cases over the search strategy where ligand alignment is guided solely by a “protomol” (a pre-computed molecular representation of an idealized ligand). Results are presented on both docking accuracy and screening utility using multiple publicly available benchmark data sets that place Surflex’s performance in the context of other molecular docking methods. In terms of docking accuracy, Surflex-Dock 2.1 performs as well as the best available methods. In the area of screening utility, Surflex’s performance is extremely robust, and it is clearly superior to other methods within the set of cases for which comparative data are available, with roughly double the screening enrichment performance.
KeywordsVirtual screening Enrichment rmsd Force field Flexibility Scoring function
The author gratefully acknowledges NIH for partial funding of the work (grant GM070481). Dr. Jain is indebted to Max Cummings for sharing the J&J set, Emanuele Perola for sharing the Vertex Set and performance data, to Bob Clark and Essam Metwally for identifying structural inconsistencies within the original Pham set, and to Ann Cleves for comments on the manuscript. Dr. Jain has a financial interest in BioPharmics LLC, a biotechnology company whose main focus is in the development of methods for computational modeling in drug discovery. Tripos Inc., has exclusive commercial distribution rights for Surflex-Dock, licensed from BioPharmics LLC.
- 14.Schulz-Gasch T, Stahl M (2003) J Mol Model (Online) 9:47–57Google Scholar
- 21.Jain AN (2004) Curr Opin Drug Discov Devel 7:396–403Google Scholar
- 26.Perkins E, Sun D, Nguyen A, Tulac S, Francesco M, Tavana H, Nguyen H, Tugendreich S, Barthmaier P, Couto J, Yeh E, Thode S, Jarnagin K, Jain AN, Morgans D, Melese T (2001) Cancer Res 61:4175–4183Google Scholar
- 41.Fletcher R (1987) Practical methods of optimization, 2nd edn. Wiley-Interscience, New YorkGoogle Scholar